# AbbVie Inc. (ABBV) — Q4-2019 Earnings Results

**Report date:** 2020-02-07 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2019

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS, Stock Up 5.86%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.21 | N/A | -1.33% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their pipeline and future prospects despite missing EPS expectations. They emphasized the strength of their existing products.

**Key quotes:**

> Management highlighted ongoing strength in key product lines.

> They noted the importance of upcoming product launches for future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a slight miss on EPS, but the stock reacted positively, rising 5.86%. Investors may be encouraged by management's focus on product strength and future launches, which could drive growth despite the EPS miss.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2019_